Design and evaluation of sustained release bilayer tablets of propranolol hydrochloride

Acta Pharmaceutica

Volumn 57, Issue 4, 2007, Pages 479-489

  Patra, Chinam Niranjan ^a   Kumar, Arethi Bharani ^a   Pandit, Hemant Kumar ^a   Singh, Satya Prakash ^a   Devi, Meduri Vimala ^a  

^a Department of Pharmaceutics   (India)

Author keywords

Bilayer tablets; Propranolol hydrochloride; Sodium starch glycolate; Statistical analysis; Water immiscible polymers

Indexed keywords

ETHYL CELLULOSE; EUDRAGIT; PROPRANOLOL; STARCH GLYCOLATE SODIUM;

ANALYSIS OF VARIANCE; ARTICLE; DISSOLUTION; DRUG DESIGN; DRUG SYNTHESIS; IN VITRO STUDY; SUSTAINED RELEASE PREPARATION;

EID: 37648998726     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10007-007-0038-0     Document Type: Article

References (28)

1. st ed., The Pharmaceutical Press, London 1996, pp. 936-937.
2. M. J. Serlin, M. L. Orme, M. Maciver, G. J. Green, R. G. Sibeon and A. M. Beckenridge, Pharmacodynamics and pharmacokinetics of conventional and long acting propranolol in patients with moderate hypertension, J. Clin. Pharmcol. 15 (1983) 519-526.
3. B. Taylan, Y. Capan, O. Guven, S. Kes and A. A. Hincal, Design and evaluation of sustained release and buccal adhesive propranolol hydrochloride tablets, J. Control. Rel. 38 (1996) 11-20; DOI: 10.1016/0168-3654(95)00094-1.
4. M. A. Abraham and A. Shirwaikar, Formulation of multilayered sustained release tablets using insoluble matrix system, Indian J. Pharm. Sci. 59 (1997) 312-315.
5. J. P. Vercammen, D. Dauwe and P. Brioen, Possibility of use of Eudragit RS as a sustained release matrix agent for the incorporation of water soluble active compounds at high percentages, STP Pharma. Sci. 7 (1997) 491-497.
6. S. B. Jayaswa, K. D. Gode and S. K. Khanna, Sustained release tablet formulation of propranolol hydrochloride with Eudragit, Aust. J. Pharm. Sci. 9 (1980) 22-26.
7. S. N. Makhija and P. R. Vavia, Once daily sustained release tablets of venlafaxine, a novel antidepressant, Eur. J. Pharm. Biopharm. 54 (2002) 9-15; DOI: 10.1016/S0939-6411 (02) 00049-8.
8. P. R. Katikaneni, S. M. Upadrashta, S. H. Neau and A. K. Mitra, Ethylcellulose matrix controlled release tablets of a water soluble drug, Int. J. Pharm. 123 (1995) 119-125; DOI: 10.1016/0378-5173(95) 00060-V.
9. G. Shlieout and G. Zessin, Investigation of ethylcellulose as a matrix former and a new method to regard and evaluate the compaction data, Drug Dev. Ind. Pharm. 22 (1996) 313-319.
10. I. Pather, I. Russell, J. A. Syce and S. H. Neau, Sustained release theophylline tablets by direct compression, Part 1: formulation and in vitro testing, Int. J. Pharm. 164 (1998) 1-10; DOI: 10.1016/S0378- 5173(97)00348-7.
11. S. M. Upadrashta, P. R. Katikaneni, G. A. Hileman and P. R. Keshary, Direct compression controlled release tablets using ethylcellulose matrices, Drug Dev. Ind. Pharm. 199 (1993) 449-460.
12. th ed., Bailliere Tindall, London 1996, pp. 663-666.
13. th ed. (Eds. L. L. Bruton, J. S. Laro and K. L. Parker), McGraw-Hill Medical Publishing Division, London 2006, pp. 1863.
14. nd ed. (Ed. M. E. Aulton), Churchill Livingstone, London 2002, pp. 207-208.
15. th ed., Lippincott Williams and Wilkins, Baltimore 2002, pp. 446-448.
16. th ed., Lippincott Williams &Wilkins, Philadelphia 2002, pp. 204-209.
17. USP 24/NF 19, USP Convention, Rockville 1999, pp. 1429.
18. H. A. Merchant, H. M. Shoaib, J. Tazeen and R. I. Yousuf, Once-daily tablet formulation and in vitro release evaluation of cefpodoxime using hydroxypropyl methylcellulose: A technical note, AAPS Pharm. Sci. Tech. 7 (2006) Article 78; DOI: 10.1028/pt 070378.
19. th ed. (Eds. G. S. Banker and C. T. Rhodes), Marcel Dekker, New York 2002, pp. 67-92.
20. T. Higuchi, Mechanism of sustained action medication, J. Pharm. Sci. 52 (1963) 1145-1149.
21. R. W. Korsmeyer, R. Gurny, E. Docler, P. Buri and N. A. Peppas, Mechanism of solute release from porous hydrophilic polymers, Int. J. Pharm. 15 (1983) 25-35; DOI: 10.1016/0378-5173(83)90064-9.
22. A. Stamm and J. C. Tritsch, Some consideration on the liberation of drugs from inert matrices, Drug Dev. Ind. Pharm. 12 (1986) 2337-2353.
23. C. S. Lafuente, M. T. Fauci, M. F. Arevelo, J. A. Fuentes, A. M. Rabasco and P. Mura, Development of sustained release tablets of didanosine containing methacrylic and ethylcellulose polymers, Int. J. Pharm. 234 (2002) 213-221; DOI. 10.1016/S0378-5173(10)00962-0.
24. M. Guyot and F. Fawaz, Nifedipine loaded polymeric microspheres: preparation and physical characteristics, Int. J. Pharm. 175 (1998) 61-74; DOI: 10.1016/S0378-5173(98)00253-1.
25. N. A. Peppas, Analysis of Fickian and non Fickian drug release from polymers, Pharm. Acta Helv. 60 (1985) 110-111.
26. J. Akubuga, Preparation and evaluation of controlled release furosemide microspheres by spherical crystallization, Int. J. Pharm. 53 (1989) 99-105; DOI: 10.1016/0378-5173(89)90233-0.
27. Y. Kawashima, T. Niwa, T. Handa, H. Takeuchi, T. Iwamoto and K. Itoh, Preparation of controlled release microspheres of ibuprofen with acrylic polymers by a novel quasi-emulsion solvent diffusion, J. Pharm. Sci. 78 (1989) 68-72.
28. S. Haznedar and B. Dortunc, Preparation and in vitro evaluation of eudragit microspheres containing acetazolamide, Int. J. Pharm. 269 (2004) 131-140; DOI: 10.1016/J.ijpharm.2003.09.015.